Octavio Espinoza

Entity
Individual
Business address
C/O Ligand Pharmaceuticals Inc, 3911 Sorrento Valley Boulevard, Ste 110, 92121 San Diego, CA
Signature Ownership
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Octavio Espinoza has filed 33 SEC EDGAR filings since 11/7/2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT Jul 2, 2025 Jun 30, 2025 001-33093
3/A Open Document Open Filing PRIMARY DOCUMENT Jul 2, 2025 Nov 1, 2022 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT May 13, 2025 May 9, 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Mar 6, 2025 Mar 4, 2025 001-33093
144 Open Document Open Filing Mar 4, 2025
4 Open Document Open Filing PRIMARY DOCUMENT Feb 19, 2025 Feb 14, 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Dec 26, 2024 Dec 23, 2024 001-33093
144 Open Document Open Filing Dec 23, 2024
4 Open Document Open Filing PRIMARY DOCUMENT Dec 6, 2024 Dec 5, 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Sep 24, 2024 Sep 20, 2024 001-33093
144 Open Document Open Filing Sep 20, 2024
4 Open Document Open Filing PRIMARY DOCUMENT Sep 19, 2024 Sep 17, 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Aug 30, 2024 Aug 28, 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Jul 2, 2024 Jun 28, 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT May 17, 2024 May 15, 2024 001-33093
144 Open Document Open Filing May 17, 2024
144 Open Document Open Filing May 16, 2024
144 Open Document Open Filing May 15, 2024
4 Open Document Open Filing PRIMARY DOCUMENT Feb 29, 2024 Feb 27, 2024 001-33093
144/A Open Document Open Filing Feb 29, 2024
144 Open Document Open Filing Feb 28, 2024
4 Open Document Open Filing PRIMARY DOCUMENT Feb 16, 2024 Feb 15, 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Dec 6, 2023 Dec 5, 2023 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Oct 3, 2023 Oct 1, 2023 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT Jul 10, 2023 Jun 30, 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Feb 27, 2023 Feb 23, 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Feb 17, 2023 Feb 15, 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Jan 4, 2023 Dec 30, 2022 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Dec 27, 2022 Dec 22, 2022 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Dec 15, 2022 Dec 13, 2022 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Dec 1, 2022 Nov 30, 2022 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Nov 10, 2022 Nov 9, 2022 001-33093
3 Open Document Open Filing FORM 3 SUBMISSION Nov 7, 2022 Nov 1, 2022 001-33093